Successful Grant Applications for LifeScience Projects
GRANT DEADLINES
Below you find a list with the most important funding programs including the deadlines for proposal submission.
If you need further information regarding the programs, please call us: +49 30 7720 5920 or contact us via email: info@consultech.de.
Last update on September 14th, 2023 (information is provided without guarantee - we try to implement updates as quickly as possible)
Health
German Programmes
Horizon Europe
Legende:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Call-ID | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
16.01.2024 |
|---|---|---|---|---|---|---|
| STAYHLTH-01-02 | Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society | 8-10 | RIA (Blind evaluation pilot, Lump sum) | 30 | 2 | 19.09.23 |
| STAYHLTH-01-05 | Personalised prevention of non-communicable diseases - addressing areas of unmet needs using multiple data sources | 8-12 | RIA (Blind evaluation pilot, Lump sum) | 50 | 2 | 19.09.23 |
| ENVHLTH-02-06 | The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution | 7-8 | RIA (blind evaluation pilot, lump sum) | 60 | 2 | 19.09.23 |
| DISEASE-07-01 | European Partnership on Rare Diseases | ~ 50 | CSA | 50 | 1 | 19.09.23 |
| DISEASE-03-08 | Comparative effectiveness research for healthcare interventions in areas of high public health need | 6-7 | RIA (blind evaluation pilot, lump sum) | 45 | 2 | 19.09.23 |
| DISEASE-03-11 | Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness | 8-10 | RIA (blind evaluation pilot, lump sum) | 30 | 2 | 19.09.23 |
| DISEASE-03-13 | Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders | 6-8 | RIA (blind evaluation pilot, lump sum) | 25 | 2 | 19.09.23 |
| DISEASE-03-14 | Tackling high-burden for patients, under-researched medical conditions | 6-7 | RIA (blind evaluation pilot, lump sum) | 25 | 2 | 19.09.23 |
| CARE-04-04 | Access to health and care services for people in vulnerable situations | 4-6 | RIA (blind evaluation pilot, lump sum) | 30 | 2 | 19.09.23 |
| TOOL-05-06 | Innovative non-animal human-based tools and strategies for biomedical research | 4-8 | RIA (blind evaluation pilot, lump sum) | 25 | 2 | 19.09.23 |
| HORIZON-EIC-2023-TRANSITION CHALLENGES-01 | Challenge: Full scale Micro-Nano-Bio devices for medical and medical research applications | 2,5 | 100% | 60,5 (all EIC transitions) |
1 | 27.09.23 |
| HORIZON-JU-GH-EDCTP3-2023-02-01-two-stage | Improving modes of delivery, deployment, and uptake of vaccines through phase IV/implementation research | 5 | RIA | 26 | 2 | 28.09.23 |
| HORIZON-JU-GH-EDCTP3-2023-02-02-two-stage | Advancing point-of-care diagnostics to the market | 5 | RIA | 30 | 2 | 28.09.23 |
| HORIZON-EIC-2023-ACCELERATOR CHALLENGES-01 | EIC Challenge: Novel biomarker-based assays to guide personalised cancer treatment | max. 2,5 Mio grant + 0.5-15 Mio investment | 70% | 523,49 (all EIC chall.) | 3 | 04.10.23 |
| HORIZON-EIC-2023-ACCELERATOR CHALLENGES-02 | EIC Challenge: Aerosol and surface decontamination for pandemic management | max. 2,5 Mio grant + 0.5-15 Mio investment | 70% | 523,49 (all EIC chall.) | 3 | 04.10.23 |
| EU4H-2023-PJ-01 | Support access to medical devices for cross border health threats (HERA) (CP-g-23-13) | 1 | Project Grant (60 - 80 %) | 1,75 | 1 | 17.10.23 |
| EU4H-2023-PJ-02 | Support stakeholders on the prevention of NCDs in the area of chronic respiratory diseases (DP-g-23-31-02) | 3 | Project Grant (60 - 80 %) | 1 | 1 | 17.10.23 |
| EU4H-2023-PJ-03 | Prevention of NCDs in the area of mental health including actions supporting vulnerable population groups, such as migrants, refugees, Roma people and displaced people from Ukraine (DP-g-23-32-02 ) | 4 | Project Grant (60 - 80 %) | 2,36 | 1 | 17.10.23 |
| EU4H-2023-PJ-04 | Prevention of NCDs in the area of dementia and other neurological disorders (DP-g-23-33-02 ) | 3 | Project Grant (60 - 80 %) | 1 | 1 | 17.10.23 |
| EU4H-2023-PJ-05 | Implementation of the agenda for medical ionising radiation applications (Samira action plan)– organisation of clinical audit campaigns as a tool to improve quality and safety of medical applications of ionising (CR-g-23-44-01) | 4 | Project Grant (60 - 80 %) | 1,5 | 1 | 17.10.23 |
| EU4H-2023-PJ-06 | Action grants on mental health challenged for cancer patients and survivors subtopic a) mental health and cancer (CR-g-23-19.02) | 7 | Project Grant (60 - 80 %) | 8 | 1 | 17.10.23 |
| EU4H-2023-PJ-07 | Action grants on mental health challenges for cancer patients and survivors Sub-topic (b): European Code for Mental Health (CR-g-23-19.02) | 1 | Project Grant (60 - 80 %) | 2 | 1 | 17.10.23 |
| EU4H-2023-PJ-08 | Action grants on the safety and quality of new Substances of Human Origin (Breast milk, faecal microbiota transplants) (a) HS-g-23-50.01 Breast milk (HS-g-23-50.01) | 1 | Project Grant (60 - 80 %) | 0,4 | 1 | 17.10.23 |
| EU4H-2023-PJ-09 | Action grants on the safety and quality of new Substances of Human Origin (Breast milk, faecal microbiota transplants) (b) HS-g-23-50.02 Faecal microbiotic transplants (HS-g-23-50.02) | 1 | Project Grant (60 - 80 %) | 0,4 | 1 | 17.10.23 |
| EU4H-2023-PJ-10 | Action grants on Facilitating Organ Paired Exchange (HS-g-23-51 ) | 1 | Project Grant (60 - 80 %) | 0,6 | 1 | 17.10.23 |
| EU4H-2023-PJ-11 | Program on orphan medical devices, in particular targeting paediatric patients (HS-g-23-65 ) | 2 | Project Grant (60 - 80 %) | 0,5 | 1 | 17.10.23 |
| EU4H-2023-PJ-12 | Action grants to contribute to the organisations of conference and events (OA-g-23-89 ) | 3 | Project Grant (60 - 80 %) | 0,45 | 1 | 17.10.23 |
| EIC Pathfinder |
Challenge: Precision nutrition | 4 | 100% | 163,5 (all EIC pathfinder) | 1 | 18.10.2023 |
| HORIZON-JU-IHI-2023-04-01-two-stage | Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical safety assessment | ~ 4,5 | RIA | 83 (for Call 4) | 2 | 08.11.2023 |
| HORIZON-JU-IHI-2023-04-02-two-stage | Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare | ~ 4,5 | RIA | 83 (for Call 4) |
2 | 08.11.2023 |
| HORIZON-JU-IHI-2023-04-03-two-stage | Inclusive clinical studies for equitable access to clinical research in Europe | ~ 4,5 | RIA | 83 (for Call 4) | 2 | 08.11.2023 |
| HORIZON-JU-IHI-2023-04-04-two-stage | Establishing novel approaches to improve clinical trials for rare and ultra-rare diseases | ~ 4,5 | RIA | 83 (for Call 4) | 2 | 08.11.2023 |
| HORIZON-JU-IHI-2023-04-05-two-stage | Safe & sustainable by design (SSbD) packaging and single use device solutions for healthcare products | ~ 4,5 | RIA | 83 (for Call 4) | 2 | 08.11.2023 |
| HORIZON-JU-IHI-2023-04-06-two-stage | Sustainable circular development and manufacturing of healthcare products and their quantitative environmental impact assessment | ~ 4,5 | RIA | 83 (for Call 4) | 2 | 08.11.2023 |
| DRS-01-01 | Improving social and societal preparedness for disaster response and health emergencies | ~ 4 | RIA | 8 | 1 | 23.11.23 |
| HORIZON-JU-IHI-2023-05-01 | Accelerating the implementation of new approach methodologies and other innovative non-animal approaches for the development, testing and production of health technologies | 10-12 | RIA | 115 (for Call5) | 1 | 16.01.24 |
| HORIZON-JU-IHI-2023-05-02 | Development and proof of principle of new clinical applications of theranostics solutions | 10-12 | RIA | 115 (for Call5) | 1 | 16.01.24 |
| HORIZON-JU-IHI-2023-05-03 | Improved prediction, detection, and treatment approaches for comprehensive stroke management | 10-12 | RIA | 115 (for Call5) | 1 | 16.01.24 |
| HORIZON-JU-IHI-2023-05-04 | Maximising the potential of synthetic data generation in healthcare applications | 10-12 | RIA | 115 (for Call5) | 1 | 16.01.24 |
| RESILIENCE-01-36 | Advanced biomaterials for the Health Care | 6-8 | IA (blind evaluation pilot, lump sum) | 31 | 2 | 07.02.24 |
| TOOL-11-02 | Bio-printing of living cells for regenerative medicine | 6-8 | RIA | 25 | 1 | 11.04.24 |
| IND-06-08 | Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs) | 8-10 | RIA | 10 | 1 | 11.04.24 |
| IND-06-09 | Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators | ~ 2 | CSA | 2 | 1 | 11.04.24 |
| DISEASE-08-12 | Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness | ~ 2 | CSA | 2 | 1 | 11.04.24 |
| DISEASE-08-20 | Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential | 7-8 | RIA | 50 | 1 | 11.04.24 |
| DISEASE-09-01 | European Partnership: One Health Anti-Microbial Resistance | ~ 100 | COFUND | 100 | 1 | 11.04.24 |
Other internationale programmes
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Funding Organisation / Programme |
Title / Topic | Deadline |
|---|---|---|
| CEPI - Coalition for Epidemic Preparedness Innovations | Controlled Human Infection Models for Beta-Coronaviruses | 15.09.2023 |
| CEPI - Coalition for Epidemic Preparedness Innovations | CHIKVACCINE Late-stage clinical development and equitable access of Chikungunya vaccines in endemic countries | 15.09.2023 |
| Global Health EDCTP3 Joint Undertaking (GH EDCTP3) | Improving modes of delivery, deployment, and uptake of vaccines through phase IV/ implementation research (RIA) | 28.09.2023 |
| Global Health EDCTP3 Joint Undertaking (GH EDCTP3) | Advancing point-of-care diagnostics to the market (RIA) | 28.09.2023 |
| DFG/ UKRI | Integrative Microbiome (academia only) | 10.10.2023 |
| CEPI - Coalition for Epidemic Preparedness Innovations | Vaccine manufacturability focused on speed | 15.12.2023 |
Biotech / Bioeconomy
German programmes
| Programm | Einreichungsdatum |
|---|---|
| SPRIND: Challenge - Circular Biomanufacturing | 17.09.2023 |
| BMBF: KMU-innovativ Bioökonomie | 15.10.2023 |
| BMBF: KMU-innovativ Ressourceneffizienz und Klimaschutz | 15.10.2023 |
| BMWK: Nutzung und den Bau von Demonstrationsanlagen in der Bioökonomie | 15.10.2023 |
| BMBF: GO-Bio initial | 15.02.2024 |
| BMWK: Nutzung und den Bau von Demonstrationsanlagen in der Bioökonomie | 01.03.2024 |
Horizont Europa
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
Other international programmes
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Funding Organisation / Programme |
Title / Topic | Deadline |
|---|---|---|
| Circular Bio-based Europe Joint Undertaking (CBE JU) Innovation actions - flagship |
Optimised and integrated woody-based value chains (IA-flagship) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Innovation actions - flagship |
Expansion and/or retro-fitting of biorefineries towards higher-value bio-based chemicals and intermediates (IA-flagship) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Innovation actions - flagship |
Bio-based packaging materials with improved properties: barrier, food contact, forming, printability, safety, recyclability/circularity-by-design (IA-flagship) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Innovation actions - flagship |
Valorisation of aquatic biomass waste and residues (IA-flagship) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Innovation actions |
Small-scale biorefining in rural areas (IA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Innovation actions |
Production of safe, sustainable, and efficient bio-based fertilisers to improve soil health and quality (IA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Innovation actions |
Improve fermentation processes (including downstream purification) to final bio-based products (IA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Innovation actions |
Recycling bio-based plastics increasing sorting and recycled content (upcycling) (IA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Innovation actions |
Development of scalable, safe bio-based surfactants with an improved sustainability profile (IA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Innovation actions |
Selective, sustainable production routes towards bio-based alternatives to fossil-based chemical building blocks (IA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Innovation actions |
High performance, circular-by design, bio-based composites (IA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Research and innovation actions |
Phyto-management; curing soil with industrial crops, utilising contaminated and saline land for industrial crop production (RIA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Research and innovation actions |
Optimised forest-based value chains for high-value applications and improved forest management (RIA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Research and innovation actions |
Robust and optimised industrial biotech and chemical/industrial biotech processes (RIA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Research and innovation actions |
Development of novel, high-performance bio-based polymers and co-polymers (RIA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Research and innovation actions |
Pre-normative research to develop standards for biodegradability of bio-based products in controlled and open environments (RIA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Coordination and support actions |
EU-wide network of pilot plants and testing facilities, improving SMEs and start-ups' access to scale-up (CSA) |
20.09.2023 |
| Circular Bio-based Europe Joint Undertaking (CBE JU) Coordination and support actions |
Supporting the capacity of regions in environmental sustainability assessment for the bio-based sectors (CSA) |
20.09.2023 |
IT in Life Sciences
German programmes
| Programme | Deadline |
|---|---|
| BMBF: KMU-innovativ Informations- und Kommunikationstechnologien | 15.10.2023 |
| BMBF: KMU-innovativ Interaktive Technologien für Gesundheit und Lebensqualität | 15.10.2023 |
| BMBF: Erforschung, Entwicklung und Nutzung von Methoden der Künstlichen Intelligenz in KMU | 15.10.2023 |
| BMBF: Entwicklung und Erprobung von neuen Ansätzen der Datenanalyse und des Datenteilens in der Long-/Post-COVID-19-Forschung | 11.12.2023 |
| BMBF: Interdisziplinäre Projekte zur Entwicklung und Erprobung von neuen Ansätzen der Datenanalyse und des Datenteilens in der Krebsforschung | 18.12.2023 |
| BMBF: Flexible, resiliente und effiziente Machine-Learning-Modelle | 12.01.2024 |
| BMBF: START-interaktiv: Interaktive Technologien für Gesundheit und Lebensqualität | 15.01.2024 |
Horizon Europe
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
Other international programmes
| Funding Organisation / Programme |
Title / Topic | Deadline |
|---|---|---|
| PHArA-ON project (Horizon 2020 funded) | Second Open Call focusing on digital solutions for the ageing society | 30.09.2023 |
Start-up Programmes
German programmes
| Programme | Deadline |
|---|---|
| BMBF: Enabling Start-up: Unternehmensgründungen in den Quantentechnologien und der Photonik | laufend |
| DBU: Green Start-up-Programm | laufend |
| BMWK: EXIST-Women (Gründung) | 30.09.2023 |
| BMBF: START-interaktiv: Interaktive Technologien für Gesundheit und Lebensqualität | 15.01.2024 |
| BMBF: Ideenwettbewerb „Neue Produkte für die Bioökonomie“ im Rahmen der „Nationalen Bioökonomiestrategie" | 01.02.2024 |
Horizon Europe
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Call-ID | Deadline | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| EIC Transition (Proposals must build on eligible EU-funded project results) | *** overall budget transition challenges | |||||
| HORIZON-EIC-2023-TRANSITIONOPEN-01 | 27.09.2023 | EIC Transition Open | 2,5 | 100% | 67,86 | 1 |
| HORIZON-EIC-2023-TRANSITIONCHALLENGES-01 | 27.09.2023 | Challenge: Full scale Micro-Nano-Bio devices for medical and medical research applications | 2,5 | 100% | 60,5*** | 1 |
| HORIZON-EIC-2023-TRANSITIONCHALLENGES-02 | 27.09.2023 | Challenge: Environmental intelligence | 2,5 | 100% | 60,5*** | 1 |
| HORIZON-EIC-2023-TRANSITIONCHALLENGES-03 | 27.09.2023 | Challenge: Chip-scale optical frequency combs | 2,5 | 100% | 60,5*** | 1 |
| EIC Accelerator (new deadlines for main proposals) |
* overall budget accelerator challenges | |||||
| HORIZON-EIC-2023-ACCELERATOROPEN-01 | Main proposal: 19.10.2023 |
EIC Accelerator 2023 Open | max. 2,5 Mio grant + 0.5-15 Mio investment | 70% | 611,75 | 3 |
| HORIZON-EIC-2023-ACCELERATORCHALLENGES-01 | Main proposal: 19.10.2023 |
Challenge: Novel biomarker-based assays to guide personalised cancer treatment | max. 2,5 Mio grant + 0.5-15 Mio investment | 70% | 523,49* | 3 |
| HORIZON-EIC-2023-ACCELERATORCHALLENGES-02 | Main proposal: 19.10.2023 |
Challenge: Aerosol and surface decontamination for pandemic management | max. 2,5 Mio grant + 0.5-15 Mio investment | 70% | 523,49* | 3 |
| HORIZON-EIC-2023-ACCELERATORCHALLENGES-03 | Main proposal: 19.10.2023 |
Challenge: Energy storage |
max. 2,5 Mio grant + 0.5-15 Mio investment | 70% | 523,49* | 3 |
| HORIZON-EIC-2023-ACCELERATORCHALLENGES-04 | Main proposal: 19.10.2023 |
Challenge: New European Bauhaus and Architecture, Engineering and Construction digitalisation for decarbonisation | max. 2,5 Mio grant + 0.5-15 Mio investment | 70% | 523,49* | 3 |
| HORIZON-EIC-2023-ACCELERATORCHALLENGES-05 | Main proposal: 19.10.2023 |
Challenge: Emerging semiconductor or quantum technology components | max. 2,5 Mio grant + 0.5-15 Mio investment | 70% | 523,49* | 3 |
| HORIZON-EIC-2023-ACCELERATORCHALLENGES-06 | Main proposal: 19.10.2023 |
Challenge: Novel technologies for resilient agriculture |
max. 2,5 Mio grant + 0.5-15 Mio investment | 70% | 523,49* | 3 |
| HORIZON-EIC-2023-ACCELERATORCHALLENGES-07 | Main proposal: 19.10.2023 |
Challenge: Customer-driven, innovative space technologies and services | max. 2,5 Mio grant + 0.5-15 Mio investment | 70% | 523,49* | 3 |
| EIC Pathfinder | ** overall budget pathfinder challenges | |||||
| HORIZON-EIC-2023-PATHFINDERCHALLENGES-01-01 | 18.10.2023 | Challenge: Clean and efficient cooling | 4 | 100% | 163,5** | 1 |
| HORIZON-EIC-2023-PATHFINDERCHALLENGES-01-02 | 18.10.2023 | Challenge: AEC digitalisation for a new triad of design, fabrication, and materials | 4 | 100% | 163,5** | 1 |
| HORIZON-EIC-2023-PATHFINDERCHALLENGES-01-03 | 18.10.2023 | Challenge: Presicion nutrition | 4 | 100% | 163,5** | 1 |
| HORIZON-EIC-2023-PATHFINDERCHALLENGES-01-04 | 18.10.2023 | Challenge: Responsible electronics | 4 | 100% | 163,5** | 1 |
| HORIZON-EIC-2023-PATHFINDERCHALLENGES-01-05 | 18.10.2023 | Challenge: In-space solar energy | 4 | 100% | 163,5** | 1 |
Plants, environment, climate, agriculture
German programmes
| Programme | Deadline |
|---|---|
| BMBF: Quantentechnologische und photonische Systemlösungen für Herausforderungen des Umwelt- und Klimaschutzes, der Biodiversität, der nachhaltigen Energiesysteme und der Ressourcenschonung | 29.09.2023 |
| BMBF: KMU-innovativ Bioökonomie | 15.10.2023 |
| BMBF: KMU-innovativ Ressourceneffizienz und Klimaschutz | 15.10.2023 |
| Deutsche Innovationspartnerschaft Agrar (DIP) - Innovationsförderung | 15.02.2024 |
Horizon Europe
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
Other international programmes
| Funding Organisation / Programme |
Title / Topic | Deadline |
|---|---|---|
| Biodiversa+ (European Biodiversity Partnership) | Synergies and trade-offs of Nature-based solutions in the context of human well-being | tba (November 2023) |
| Biodiversa+ (European Biodiversity Partnership) | Nature-based solutions mitigating anthropogenic drivers of biodiversity loss | tba (November 2023) |
| Biodiversa+ (European Biodiversity Partnership) | The contribution of Nature-based solutions for just transformative change | tba (November 2023) |
Open calls
German programmes
| Programme | Deadline |
|---|---|
| Bund: Steuerliche Forschungszulage - für alle F&E Aktivitäten, auch rückwirkend | laufend |
| BMWK: Zentrales Innovationsprogramm Mittelstand - ZIM (themenoffen) | laufend |
| BMWK: "Digital jetzt" - Investitionsförderung für KMU | laufend |
| BMWK: ZIM international- verschiedene Länderpartnerschaften mit Deutschland | verschiedene Deadlines |
| EUREKA: Eurostars | 14.09.2023 |
| BMBF: Integration der Region Mittelost- und Südosteuropa in den Europäischen Forschungsraum (Bridge2ERA2021) | 27.09.2023 |
| BMBF: Grenzüberschreitende Vernetzung und Entwicklung von Projektvorschlägen für Verbundvorhaben des EU-Rahmenprogramms für Forschung und Innovation Horizont Europa | 30.09.2023 |
| BMBF: KMU innovativ - Zukunft der Wertschöpfung | 15.10.2023 |
| EUREKA: Eurostars | 14.03.2024 |
| Integration der Region Mittelost- und Südosteuropa in den Europäischen Forschungsraum (Bridge2ERA2021) | 31.05.2024 |
Horizon Europe
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Call-ID | Deadline | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| HORIZON-EIC-2023-ACCELERATOROPEN-01 | Main proposal: 19.10.2023 |
EIC Accelerator 2023 Open | max. 2,5 Mio grant + 0.5-15 Mio investment | 70% | 611,75 | 3 |
| HORIZON-EIC-2023-TRANSITIONOPEN-01 | 27.09.2023 | EIC Transition Open | 2,5 | 100% | 67,86 | 1 |
Other international programmes
| Programme | Deadine |
|---|---|
| BMWK: ZIM international- Several options between Germany and other countries | verschiedene Deadlines |
| EUREKA: Eurostars | 14.09.2023 |
| IraSME – International research activities by small and medium-sized enterprises: 32nd call | 27.09.2023 |
| IraSME – International research activities by small and medium-sized enterprises: 33rd call | 27.03.2024 |